Carl W Dieffenbach

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. doi request reprint Preventing HIV transmission through antiretroviral treatment-mediated virologic suppression: aspects of an emerging scientific agenda
    Carl W Dieffenbach
    Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA
    Curr Opin HIV AIDS 7:106-10. 2012
  2. pmc Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities
    Susan C Kim
    O Neill Institute for National and Global Health Law, Georgetown University, Washington, DC, USA
    J Int AIDS Soc 13:24. 2010
  3. doi request reprint Thirty years of HIV and AIDS: future challenges and opportunities
    Carl W Dieffenbach
    National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892, USA
    Ann Intern Med 154:766-71. 2011
  4. ncbi request reprint HIV vaccine development: Lessons from the past, informing the future
    James Bradac
    National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    IDrugs 12:435-9. 2009
  5. doi request reprint HIV vaccine research: the way forward
    Anthony S Fauci
    National Institute of Allergy and Infectious Diseases, National Institutes of Health, 31 Center Drive, Bethesda, MD 20892, USA
    Science 321:530-2. 2008
  6. pmc Rethinking prevention of HIV type 1 infection
    David N Burns
    Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
    Clin Infect Dis 51:725-31. 2010
  7. ncbi request reprint Defining and solving the essential protein-protein interactions in HIV infection
    Diana Finzi
    National Institute of Allergy and Infectious Diseases, Division of AIDS, National Institutes of Health, Bethesda, MD 20892, USA
    J Struct Biol 158:148-55. 2007
  8. pmc Defective virus drives human immunodeficiency virus infection, persistence, and pathogenesis
    Diana Finzi
    Basic Sciences Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892, USA
    Clin Vaccine Immunol 13:715-21. 2006

Collaborators

Detail Information

Publications8

  1. doi request reprint Preventing HIV transmission through antiretroviral treatment-mediated virologic suppression: aspects of an emerging scientific agenda
    Carl W Dieffenbach
    Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA
    Curr Opin HIV AIDS 7:106-10. 2012
    ....
  2. pmc Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities
    Susan C Kim
    O Neill Institute for National and Global Health Law, Georgetown University, Washington, DC, USA
    J Int AIDS Soc 13:24. 2010
    ..This paper identifies the key action points that emerged from the Planning for PrEP meeting...
  3. doi request reprint Thirty years of HIV and AIDS: future challenges and opportunities
    Carl W Dieffenbach
    National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892, USA
    Ann Intern Med 154:766-71. 2011
    ..6 million per year globally, is critical to any attempt to end this pandemic. This article addresses each of these challenges and provides directions for the future...
  4. ncbi request reprint HIV vaccine development: Lessons from the past, informing the future
    James Bradac
    National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    IDrugs 12:435-9. 2009
    ..As a result of the insight gained, a new sense of optimism exists in the field of HIV vaccine research...
  5. doi request reprint HIV vaccine research: the way forward
    Anthony S Fauci
    National Institute of Allergy and Infectious Diseases, National Institutes of Health, 31 Center Drive, Bethesda, MD 20892, USA
    Science 321:530-2. 2008
    ..This article summarizes progress and challenges in HIV vaccine research, the priorities arising from a recent summit at NIAID, and the actions needed, some already under way, to address those priorities...
  6. pmc Rethinking prevention of HIV type 1 infection
    David N Burns
    Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
    Clin Infect Dis 51:725-31. 2010
    ..By maximizing the potential of existing interventions, developing other effective strategies, and combining them in an optimal manner, we have the opportunity to bring the HIV-1 epidemic under control...
  7. ncbi request reprint Defining and solving the essential protein-protein interactions in HIV infection
    Diana Finzi
    National Institute of Allergy and Infectious Diseases, Division of AIDS, National Institutes of Health, Bethesda, MD 20892, USA
    J Struct Biol 158:148-55. 2007
    ..We have chosen to focus our attention on certain aspects of the HIV replication cycle where we think that structural information would contribute substantially to the development of new therapeutic and vaccine targets for HIV...
  8. pmc Defective virus drives human immunodeficiency virus infection, persistence, and pathogenesis
    Diana Finzi
    Basic Sciences Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892, USA
    Clin Vaccine Immunol 13:715-21. 2006